3M Drug Delivery Systems to offer tablet manufacturing

Recently completed manufacturing upgrades and approved foreign trade zone status highlight new California service

3M Drug Delivery Systems (DDS; St. Paul, MN), a division of 3M, has expanded its outsourcing capabilities to provide contract tablet manufacturing at its Northridge, California pharmaceutical production plant. 3M DDS has more than 50 years of experience manufacturing tablets, creams, metered dose inhalers, and transdermal patches. "Now we are offering our solid dose manufacturing expertise and capability to contract partners," said Doug Patton, business manager. "We have already received a very positive response and our hope is that many other pharmaceutical firms will consider use of 3M's high-quality manufacturing capacity."

3M DDS has upgraded their Northridge, California facility to improve their tablet manufacturing service, which is supported by full regulatory and analytical expertise and provides a broad range of tablet sizes, shapes, and coatings. The cGMP facility, located in a U.S. West Coast approved foreign trade zone, potentially provides 3M DDS's contract manufacturing customers substantial savings by eliminating the duties normally paid on imported drug excipients and components.

"In addition to our trade zone status, our West Coast geographic location provides a benefit to western pharmaceutical companies, while providing our eastern pharmaceutical customers with a new alternative manufacturing site," said Patton.

3M DDS has been in the contract manufacturing business for several decades. "Over the years, we have been known as the primary source for the manufacturing of metered dose inhalers and transdermal products," Patton stated. "With the addition of our solid dose capabilities to our contract business, we can now open the door to new customers. We welcome all inquiries regarding opportunities, large and small, about our new manufacturing service."

For more information, contact Sue Thoreson of 3M Drug Delivery Systems at 651-736-3549.

Edited by Angelo DePalma
Managing Editor, Pharmaceutical Online and Drug Discovery Online
Email: adepalma@vertical.net